FI62624C - Foerfarande foer framstaellning av foer intravenoest bruk laempligt gammaglobulin som inte innehaoller antikomplementaert gammaglobulin ur orent gammaglobulin - Google Patents
Foerfarande foer framstaellning av foer intravenoest bruk laempligt gammaglobulin som inte innehaoller antikomplementaert gammaglobulin ur orent gammaglobulin Download PDFInfo
- Publication number
- FI62624C FI62624C FI770290A FI770290A FI62624C FI 62624 C FI62624 C FI 62624C FI 770290 A FI770290 A FI 770290A FI 770290 A FI770290 A FI 770290A FI 62624 C FI62624 C FI 62624C
- Authority
- FI
- Finland
- Prior art keywords
- gammaglobulin
- gamma globulin
- solution
- foer
- globulin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2604759A DE2604759C2 (de) | 1976-02-07 | 1976-02-07 | Verfahren zur Gewinnung von iv-verträglichen Γglobulinen |
| DE2604759 | 1976-02-07 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI770290A7 FI770290A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1977-08-08 |
| FI62624B FI62624B (fi) | 1982-10-29 |
| FI62624C true FI62624C (fi) | 1983-02-10 |
Family
ID=5969262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI770290A FI62624C (fi) | 1976-02-07 | 1977-01-28 | Foerfarande foer framstaellning av foer intravenoest bruk laempligt gammaglobulin som inte innehaoller antikomplementaert gammaglobulin ur orent gammaglobulin |
Country Status (22)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2837168A1 (de) * | 1978-08-25 | 1980-03-06 | Blutspendedienst Dt Rote Kreuz | Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung |
| JPS60222773A (ja) * | 1984-04-19 | 1985-11-07 | Sekisui Chem Co Ltd | ラテツクス試薬の製造方法 |
| ATE59144T1 (de) * | 1984-07-07 | 1991-01-15 | Armour Pharma Gmbh | Verfahren zur herstellung von gamma-globulin zur intravenoesen anwendung. |
| DE3440444A1 (de) * | 1984-11-06 | 1986-05-07 | Dechema Deutsche Gesellschaft für chemisches Apparatewesen e.V., 6000 Frankfurt | Verfahren zur herstellung grob gekoernter schichtsilikate und deren verwendung als adsorbentien fuer proteine |
| UA64742C2 (uk) * | 1997-12-24 | 2004-03-15 | Альфа Терапевтик Корпорейшн | СПОСІБ ОДЕРЖАННЯ РОЗЧИНУ <font face="Symbol">g</font>-ГЛОБУЛІНУ, ПРИЗНАЧЕНОГО ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ, І ПРОДУКТ, ЩО ОДЕРЖУЄТЬСЯ У ЦЕЙ СПОСІБ (ВАРІАНТИ) |
| KR101917196B1 (ko) | 2014-03-11 | 2018-11-09 | 주식회사 녹십자홀딩스 | 면역글로불린의 정제방법 |
| KR101917197B1 (ko) | 2014-03-11 | 2018-11-09 | 주식회사 녹십자홀딩스 | 면역글로불린의 정제방법 |
| KR101657690B1 (ko) | 2015-06-05 | 2016-09-19 | 주식회사 녹십자홀딩스 | 혈장 유래 b형 간염 사람 면역글로불린 제제의 제조방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3449316A (en) * | 1967-03-03 | 1969-06-10 | American Cyanamid Co | Process for the purification of gamma globulin employing bentonite |
| DE2500076C3 (de) * | 1975-01-02 | 1982-11-18 | SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld | Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen |
-
1976
- 1976-02-07 DE DE2604759A patent/DE2604759C2/de not_active Expired
-
1977
- 1977-01-28 IE IE186/77A patent/IE44591B1/en unknown
- 1977-01-28 FI FI770290A patent/FI62624C/fi not_active IP Right Cessation
- 1977-01-31 SE SE7700960A patent/SE442707B/xx not_active IP Right Cessation
- 1977-01-31 NL NL7700975A patent/NL7700975A/xx not_active Application Discontinuation
- 1977-02-03 AU AU21902/77A patent/AU508852B2/en not_active Expired
- 1977-02-04 YU YU00305/77A patent/YU30577A/xx unknown
- 1977-02-04 FR FR7703139A patent/FR2340738A2/fr active Granted
- 1977-02-04 DD DD7700197241A patent/DD132758A6/xx unknown
- 1977-02-04 PL PL1977195821A patent/PL104234B3/pl unknown
- 1977-02-04 BE BE6045865A patent/BE851151R/xx not_active IP Right Cessation
- 1977-02-04 DK DK047277A patent/DK151609C/da not_active IP Right Cessation
- 1977-02-04 HU HU77PA1277A patent/HU177708B/hu unknown
- 1977-02-04 MX MX775414U patent/MX5356E/es unknown
- 1977-02-04 AT AT74177A patent/AT351672B/de not_active IP Right Cessation
- 1977-02-05 IN IN168/CAL/77A patent/IN144987B/en unknown
- 1977-02-07 JP JP1172177A patent/JPS52117414A/ja active Granted
- 1977-02-07 ES ES455708A patent/ES455708A2/es not_active Expired
- 1977-02-07 ZA ZA770684A patent/ZA77684B/xx unknown
- 1977-02-07 GB GB5017/77A patent/GB1577031A/en not_active Expired
- 1977-02-07 CA CA271,204A patent/CA1087524A/en not_active Expired
- 1977-02-07 CH CH146277A patent/CH629669A5/de not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI60022C (fi) | Foerfarande foer framstaellning av rent intravenoesdugligt gammaglobulin | |
| US4315851A (en) | Pharmaceutical composition having antitumor activity | |
| DE3877811T2 (de) | Pasteurisierbares, lyophilisierbares blutsurrogat auf haemoglobinbasis. | |
| FI62624C (fi) | Foerfarande foer framstaellning av foer intravenoest bruk laempligt gammaglobulin som inte innehaoller antikomplementaert gammaglobulin ur orent gammaglobulin | |
| EP0447585B1 (de) | Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates | |
| HU182554B (en) | Process for producing preparation of serum protein for intravenous application | |
| US4371520A (en) | Process for preparing immunoglobulin suitable for intravenous injection | |
| WO1987002679A1 (en) | Immunotherapeutic treatment | |
| US4164495A (en) | Method of recovering immunoglobulin using a polyol and an alkanoic acid | |
| FI72653C (fi) | Foerfarande foer framstaellning av ett faktor viii(ahf)-koncentrat. | |
| US3907763A (en) | Insulin derivatives crosslinked by a dicarboxylic acid moiety | |
| PL99599B1 (pl) | Sposob otrzymywania tolerowanej srodzylnie gammaglobuliny | |
| JPS58201794A (ja) | ヒトインターフェロンβの濃縮精製法 | |
| DE69002033T2 (de) | Gelfiltration von wärmebehandeltem Faktor VIII. | |
| US4476109A (en) | Method of preparing gamma globulin suitable for intravenous administration | |
| JPS6160817B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| US20030190732A1 (en) | Plasma fraction containing bikunin, method for the production thereof and use of the same | |
| US4379086A (en) | Method of preparing immunoglobulin suitable for intravenous administration using PEG | |
| FI61191B (fi) | Foerfarande foer utvinning av immunoglobulin foer intravenoes administration | |
| WO1996039428A1 (en) | Antitumor proteins from rana pipiens oocytes | |
| DE69018275T2 (de) | Peptide, deren Verwendung als Hemmer gegen Entwicklung von t-Lymphocyten und Wirksamkeit von Makrophagen und Verfahren zu deren Herstellung. | |
| EP0092186B1 (en) | Method of preparing gamma globulin suitable for intravenous administration | |
| DE1617332C3 (de) | Verfahren zum Isolieren eines wasserlöslichen Protein-Metall-Chelats mit antiphlogistischer Wirkung | |
| JPS6248698A (ja) | 新規ペプチド物質 | |
| DE69304155T2 (de) | Neue Peptid-Derivate mit Bradikyninantagonischer Wirkung, Verfahren zur deren Herstellung und pharmazeutische Zubereitungen die sie enthalten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: ARMOUR PHARMACEUTICAL COMPANY |